Nephrotic syndrome in childhood

被引:682
作者
Eddy, AA [1 ]
Symons, JM [1 ]
机构
[1] Univ Washington, Childrens Hosp & Reg Med Ctr, Dept Pediat, Div Nephrol, Seattle, WA 98105 USA
关键词
D O I
10.1016/S0140-6736(03)14184-0
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Childhood nephrotic syndromes are most commonly caused by one of two idiopathic diseases: minimal-change nephrotic syndrome (MCNS) and focal segmental glomerulosclerosis (FSGS). A third distinct type, membranous nephropathy, is rare in children. Other causes of isolated nephrotic syndrome can be subdivided into two major categories: rare genetic disorders, and secondary diseases associated with drugs, infections, or neoplasia. The cause of Idiopathic nephrotic syndrome remains unknown, but evidence suggests it may be a primary T-cell disorder that leads to glomerular podocyte dysfunction. Genetic studies in children with familial nephrotic syndrome have identified mutations in genes that encode important podocyte proteins. Patients with idiopathic nephrotic syndrome are initially treated with corticosterolds. Steroid-responsiveness is of greater prognostic use than renal histology. Several second-line drugs, including alkylating agents, ciclosporin, and levamisole, may be effective for complicated and steroid-unresponsive MCNS and FSGS patients. Nephrotic syndrome is associated with several medical complications, the most severe and potentially fatal being bacterial infections and thromboembolism. Idiopathic nephrotic syndrome is a chronic relapsing disease for most steroid-responsive patients, whereas most children with refractory FSGS ultimately develop end-stage renal disease. Research is being done to further elucidate the disorder's molecular pathogenesis, identify new prognostic indicators, and to develop better approaches to treatment.
引用
收藏
页码:629 / 639
页数:11
相关论文
共 140 条
[41]   Dominant T cells in idiopathic nephrotic syndrome of childhood [J].
Frank, C ;
Herrmann, M ;
Fernandez, S ;
Dirnecker, D ;
Böswald, M ;
Kolowos, W ;
Ruder, H ;
Haas, JP .
KIDNEY INTERNATIONAL, 2000, 57 (02) :510-517
[42]   CALCIUM AND VITAMIN-D METABOLISM IN CHILDREN WITH NEPHROTIC SYNDROME [J].
FREUNDLICH, M ;
BOURGOIGNIE, JJ ;
ZILLERUELO, G ;
ABITBOL, C ;
CANTERBURY, JM ;
STRAUSS, J .
JOURNAL OF PEDIATRICS, 1986, 108 (03) :383-387
[43]  
Frishberg Y, 2002, J AM SOC NEPHROL, V13, P400, DOI 10.1681/ASN.V132400
[44]  
Fuchshuber A, 2001, J AM SOC NEPHROL, V12, P374, DOI 10.1681/ASN.V122374
[45]   Implication of elevated serum IgE levels in minimal change nephrotic syndrome [J].
Fuke, Y ;
Endo, M ;
Ohsawa, I ;
Satomura, A ;
Hidaka, M ;
Fujita, T ;
Ohi, H .
NEPHRON, 2002, 91 (04) :769-770
[46]   Angiotensin II and progressive renal insufficiency [J].
Gaedeke, J ;
Noble, NA ;
Border, WA .
CURRENT HYPERTENSION REPORTS, 2002, 4 (05) :403-407
[47]   Circulating mediators of proteinuria in idiopathic minimal lesion nephrotic syndrome [J].
Garin, EH .
PEDIATRIC NEPHROLOGY, 2000, 14 (8-9) :872-878
[48]   PLASMA AND BLOOD VOLUMES IN PATIENTS WITH THE NEPHROTIC SYNDROME [J].
GEERS, AB ;
KOOMANS, HA ;
BOER, P ;
MEES, EJD .
NEPHRON, 1984, 38 (03) :170-173
[49]   Impact of treatment of dyslipidemia on renal function, fat deposits and scarring in patients with persistent nephrotic syndrome [J].
Gheith, OA ;
Sobh, MAK ;
Mohamed, KES ;
El-Baz, MA ;
El-Husseini, F ;
Gazarin, SS ;
Ahmed, HAEH ;
Rasem, MW ;
Amer, GM .
NEPHRON, 2002, 91 (04) :612-619
[50]   Acyclovir prophylaxis of varicella in children with renal disease receiving steroids [J].
Goldstein, SL ;
Somers, MJG ;
Lande, MB ;
Brewer, ED ;
Jabs, KL .
PEDIATRIC NEPHROLOGY, 2000, 14 (04) :305-308